# Jasper Therapeutics, Inc.: Form 8-K, filed Sep 23, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2021-09-23
- Accepted by EDGAR: Sep 22, 2021, 20:38 ET
- Period: 2021-09-22
- Accession: 0001213900-21-049423
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021049423/ea147826-8k_amplitude.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021049423/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021049423/ea147826-8k_amplitude.htm

Filed Sep 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-049423. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
